ContractClinical Study Agreement • June 12th, 2019
Contract Type FiledJune 12th, 2019CLINICAL STUDY AGREEMENT SMLOUVA O KLINICKÉM HODNOCENÍ This Clinical Study Agreement (this “Agreement”) when signed by all parties, will set forth certain agreements by and between IQVIA RDS Czech Republic s.r.o., having a place of business at Pernerova 691/42, 186 00 Praha 8 – Karlín, Czech Republic, Identification number: 247 68 651, Tax identification number: CZ24768651, represented by(“IQVIA” or “CRO”) and Fakultní nemocnice Brno, having a place of business at Jihlavská 20, 625 00 Brno, Czech Republic,Identification number: 652 69 705, Tax identification number: CZ65269705, represented by(the “Institution”) and, born ,located at(the “Investigator”) to conduct the Study (as defined below) in relation to the Investigational Product(s) (as defined below)) effective as of the date of publication of this Agreement in the Register of Agreements (the “Effective Date”). Tato smlouva o klinickém hodnocení (dále jen„Smlouva“) bude po podpisu všech smluvních stran tvořit ujednání me
ContractClinical Study Agreement • May 7th, 2019
Contract Type FiledMay 7th, 2019CLINICAL STUDY AGREEMENT - TRIPARTITE SMLOUVA O KLINICKÉM HODNOCENÍ – TROJSTRANNÁ This Clinical Study Agreement (this “Agreement”) when signed by all parties, will set forth certain agreements by and between IQVIA RDS Czech Republic s.r.o., having a place of business at Pernerova 691/42, 186 00 Praha 8 - Karlín, Czech Republic, Identification number: 24768651, Tax identification number: CZ24768651, represented by(“IQVIA” or “CRO”) and Fakultní nemocnice Královské Vinohrady, having a place of business at Šrobárova 1150/50, 100 34 Praha 10, Czech Republic, Identification number: 00064173, Tax identification number: CZ00064173, represented by, reference symbol: KH 66/2018, internal cost center no. 52141 (the “Institution”) and doc. MUDr. Jan Novák, Ph.D., having an address at ,date of birth:(the “Investigator”) to conduct the Study (as defined below) in relation to the Investigational Product(s) (as defined below)) effective as of the date of publication of this Agreement in the Reg
ContractClinical Study Agreement • August 23rd, 2018
Contract Type FiledAugust 23rd, 2018CLINICAL STUDY AGREEMENT SMLOUVA O KLINICKÉM HODNOCENÍ This Clinical Study Agreement (this “Agreement”) when signed by all parties, will set forth certain agreements by and between IQVIA RDS Czech Republic s.r.o., having a place of business at Pernerova 691/42, 186 00 Praha 8 - Karlín, Czech Republic, Identification number: 24768651, Tax identification number: CZ24768651, represented by(“IQVIA” or “CRO”) and Všeobecná fakultní nemocnice v Praze, having a place of business at U Nemocnice 499/2,128 08 Praha 2, Czech Republic, Identification number: 00064165, Tax identification number: CZ00064165, represented by Mgr. Dana Jurásková, Ph.D., MBA, Director (the “Institution”) and ,having an address at First Internal Clinic, U Nemocnice 499/2, 128 08 Praha 2, Czech Republic (the “Investigator”) to conduct the Study (as defined below) in relation to the Investigational Product(s) (as defined below)) effective as of the date of publication of this Agreement in the Register of Agreements (